REFERENCES
- Bauernfeind A, Jungwirth R. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefe-tamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefurox-ime, cefador and cefadroxil. Infection 1991; 19: 353–362.
- Cullmann W, Dick W. Cefpodoxime: comparable evalu-ation with other orally available cephalosporins. With a note on the role of β-lactamases. Zbl Bakt 1990; 273: 501–517.
- Cullmann W. Survey of antimicrobial resistance to oral antibiotics in Italy. Chemotherapy (Basel) 1993; 39: 13–21.
- Holt HA, Bywarter MJ, Reeves DS. In-vitro activity of cefpodoxime against 1834 isolates from domiciliary infection at 20 UK centres. J Antimicrob Chemother 1990; 26 (Suppl E): 7-12.
- Sheppard M, King A, Phillips I. In vitro activity of cef-podoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents. Eur J Clin Microbiol Infect Dis 1991; 10: 573–581.
- Soussy CJ, Kitzis MD, Thabaut A, et al. Activite antibacterienne in-vitro d'une nouvelle cephalosporine orale, le cefixime, Resultats d'une etude multicentrique. Pathol Biol 1989; 37: 528–533.
- Valle T, Jalanko E, Scheinin L, Renkonen OV. In vitro activity of Ro 15-8074 and Ro 19-5247. Eur J Clin Microbiol 1987; 6: 167–169.
- Wiedemann B, Luhmer E, Zuhlsdorf MT. In vitro activ-ity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa. Infection 1991; 19: 363–369.
- Wiedemann B, Luhmer E, Zuhlsdorf MT. Microbiological evaluation of cefpodoxime proxetil (see com-ments). Drugs 1991; 42 (Suppl 3): 6–12.
- Ballows A, Hausler VITJ, Herrmann KL, Isenberg HD, Shadomy HJ. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 1991.